Senior insider sale
President and CFO at BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$1.02M
13.60K shares
What this filing means
TRIMARCHI THOMAS plans to sell 13.60K shares of BRIDGEBIO PHARMA, INC. valued at approximately $1.02M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001950047-26-001308
Officer· President and CFO
Since Feb 2026
13.60K
Shares to sell
$1.02M
Approx. market value
13.60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
2/16/2025
13.60KTotal acquired13.60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/16/2025 | Restricted Stock Not Applicable | 13.60K | — |
| Total | 13.60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.60K
Market value
$1.02M
2/17/2026
Total
Units
13.60K
Value
$1.02M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/17/2026 | 13.60K | $1.02M | NASDAQ | Planned |
| Total | 13.60K | $1.02M | ||